Annual CFF
$20.47 M
+$18.22 M+809.87%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual cash flow from financing activities is $20.47 million, with the most recent change of +$18.22 million (+809.87%) on December 31, 2023.
- During the last 3 years, INTS annual CFF has risen by +$14.18 million (+225.33%).
- INTS annual CFF is now at all-time high.
Performance
INTS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$413.00 K
+$410.00 K+13666.67%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly cash flow from financing activities is $413.00 thousand, with the most recent change of +$410.00 thousand (+13666.67%) on September 30, 2024.
- Over the past year, INTS quarterly CFF has stayed the same.
- INTS quarterly CFF is now -97.99% below its all-time high of $20.52 million, reached on September 30, 2023.
Performance
INTS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$411.00 K
-$20.11 M-98.00%
September 30, 2024
Summary
- As of February 8, 2025, INTS TTM cash flow from financing activities is $411.00 thousand, with the most recent change of -$20.11 million (-98.00%) on September 30, 2024.
- Over the past year, INTS TTM CFF has stayed the same.
- INTS TTM CFF is now -98.19% below its all-time high of $22.73 million, reached on September 30, 2023.
Performance
INTS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
INTS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +809.9% | 0.0% | 0.0% |
| 3 y3 years | +225.3% | +101.5% | -83.3% |
| 5 y5 years | +430.5% | +101.5% | -83.3% |
INTS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +898.6% | -98.0% | +271.4% | -98.2% | -100.0% |
| 5 y | 5-year | at high | +898.6% | -98.0% | +271.4% | -98.2% | -100.0% |
| alltime | all time | at high | +898.6% | -98.0% | +271.4% | -98.2% | -100.0% |
Intensity Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $413.00 K(>+9900.0%) | $411.00 K(-98.0%) |
| Jun 2024 | - | $3000.00(-62.5%) | $20.52 M(+1.2%) |
| Mar 2024 | - | $8000.00(-161.5%) | $20.27 M(-1.0%) |
| Dec 2023 | $20.47 M(+809.9%) | -$13.00 K(-100.1%) | $20.47 M(-10.0%) |
| Sep 2023 | - | $20.52 M(-8614.9%) | $22.73 M(+926.9%) |
| Jun 2023 | - | -$241.00 K(-217.6%) | $2.21 M(-10.3%) |
| Mar 2023 | - | $205.00 K(-90.9%) | $2.47 M(+9.7%) |
| Dec 2022 | $2.25 M | $2.25 M(>+9900.0%) | $2.25 M(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $13.80 K(-200.0%) | $2.05 M(+0.7%) |
| Mar 2022 | - | -$13.80 K(<-9900.0%) | $2.04 M(-0.7%) |
| Dec 2021 | $2.05 M(-67.4%) | - | - |
| Dec 2021 | - | $0.00(-100.0%) | $2.05 M(0.0%) |
| Sep 2021 | - | $2.05 M(>+9900.0%) | $2.05 M(>+9900.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | $6.29 M(+63.1%) | - | - |
| Dec 2019 | $3.86 M | - | - |
FAQ
- What is Intensity Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Intensity Therapeutics?
- What is Intensity Therapeutics annual CFF year-on-year change?
- What is Intensity Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly CFF year-on-year change?
- What is Intensity Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Intensity Therapeutics?
- What is Intensity Therapeutics TTM CFF year-on-year change?
What is Intensity Therapeutics annual cash flow from financing activities?
The current annual CFF of INTS is $20.47 M
What is the all time high annual CFF for Intensity Therapeutics?
Intensity Therapeutics all-time high annual cash flow from financing activities is $20.47 M
What is Intensity Therapeutics annual CFF year-on-year change?
Over the past year, INTS annual cash flow from financing activities has changed by +$18.22 M (+809.87%)
What is Intensity Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of INTS is $413.00 K
What is the all time high quarterly CFF for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly cash flow from financing activities is $20.52 M
What is Intensity Therapeutics quarterly CFF year-on-year change?
Over the past year, INTS quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Intensity Therapeutics TTM cash flow from financing activities?
The current TTM CFF of INTS is $411.00 K
What is the all time high TTM CFF for Intensity Therapeutics?
Intensity Therapeutics all-time high TTM cash flow from financing activities is $22.73 M
What is Intensity Therapeutics TTM CFF year-on-year change?
Over the past year, INTS TTM cash flow from financing activities has changed by $0.00 (0.00%)